Bridges Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-14,121
| Closed | -$361K | – | 404 |
|
2024
Q3 | $361K | Hold |
14,121
| – | – | 0.01% | 323 |
|
2024
Q2 | $332K | Buy |
14,121
+517
| +4% | +$12.1K | 0.01% | 323 |
|
2024
Q1 | $391K | Hold |
13,604
| – | – | 0.01% | 171 |
|
2023
Q4 | $446K | Sell |
13,604
-735
| -5% | -$24.1K | 0.01% | 168 |
|
2023
Q3 | $399K | Hold |
14,339
| – | – | 0.01% | 170 |
|
2023
Q2 | $489K | Hold |
14,339
| – | – | 0.02% | 170 |
|
2023
Q1 | $431K | Buy |
14,339
+1,110
| +8% | +$33.4K | 0.02% | 176 |
|
2022
Q4 | $373K | Sell |
13,229
-1,419
| -10% | -$40.1K | 0.01% | 180 |
|
2022
Q3 | $481K | Hold |
14,648
| – | – | 0.02% | 175 |
|
2022
Q2 | $461K | Hold |
14,648
| – | – | 0.02% | 178 |
|
2022
Q1 | $673K | Buy |
14,648
+4,455
| +44% | +$205K | 0.02% | 166 |
|
2021
Q4 | $624K | Buy |
10,193
+4,245
| +71% | +$260K | 0.02% | 174 |
|
2021
Q3 | $444K | Hold |
5,948
| – | – | 0.01% | 181 |
|
2021
Q2 | $550K | Hold |
5,948
| – | – | 0.02% | 174 |
|
2021
Q1 | $528K | Hold |
5,948
| – | – | 0.02% | 173 |
|
2020
Q4 | $555K | Buy |
+5,948
| New | +$555K | 0.02% | 162 |
|